20:43:58 EDT Wed 30 Sep 2020
Enter Symbol
or Name

Login ID:

Cannabis Summary for Sept. 4, 2020

2020-09-04 21:23 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The S&P/TSX Cannabis Index lost 3.15 points to 124.16 Friday, ending the week down 8.25 points. The Canadian Securities Exchange Composite Index, meanwhile, inched up 0.47 point to 454.36 today, but ended the week down 41.02 points. Yesterday, Payton Nyquvest's psychedelic research and therapy company, Numinus Wellness Inc. (NUMI: $0.235), filed a final short-form prospectus for a $4-million financing. The financing will be led on a best-efforts basis by Mackie Research Capital Corp., the former employer of founder and chief executive officer Payton Nyquvest. (Payton Nyquvest is the son of Universal Ibogaine Inc. chairman Shayne Nyquvest.)

Under the financing, up to 16 million units will be granted to investors at 25 cents per unit. (The company currently has 95.85 million shares outstanding, so the financing will dilute current holders by about 14 per cent.) Numinus is expecting the offering to close by Sept. 10.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2020 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.